AU2021200634A1 — Pharmaceutical compostion containing acetominophen and ibuprofen
Assigned to AFT Pharmaceuticals Ltd · Expires 2021-03-04 · 5y expired
What this patent protects
It is known to take acetaminophen in combination with ibuprofen. It can be a problem, or at least a disadvantage, if these substances do not act fast enough in the body. It is an object of the invention to go at least some way towards addressing this. According to the invention…
USPTO Abstract
It is known to take acetaminophen in combination with ibuprofen. It can be a problem, or at least a disadvantage, if these substances do not act fast enough in the body. It is an object of the invention to go at least some way towards addressing this. According to the invention there is a solid oral dosage 5 form containing 325 mg (± 5%) of acetaminophen and 97.5 mg (± 5%) of ibuprofen or 500 mg (± 5%) of acetaminophen and 150 mg (± 5%) of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 pm. 0
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.